Can You Safely Take Insulin Glargine and Dapagliflozin Together? What FDA Data Shows
If your doctor has prescribed both insulin glargine and dapagliflozin, you may be wondering: Is this combination safe? Can these two diabetes medications work together without causing serious problems? The good news is that many patients do take both medications, but there are important things you need to know about how they interact and what warning signs to watch for.
The most comprehensive checker on the internet — built from over 250,000 official FDA drug labels. No account needed.
Check Interactions NowAccording to FDA drug labeling, there is no major direct drug-drug interaction between insulin glargine and dapagliflozin listed. However, both medications affect your blood sugar in different ways, and when combined, they can work together in ways that require careful monitoring. Let's break down what you need to understand about this combination.
How Each Medication Works
Insulin glargine is a long-acting insulin that helps your body use glucose (sugar) for energy. It works by replacing the insulin your pancreas no longer makes effectively. Insulin directly lowers blood sugar by moving glucose into cells.
Dapagliflozin is an SGLT2 inhibitor—a different class of medication that works through your kidneys. Instead of increasing insulin, dapagliflozin helps your kidneys remove excess glucose through urine, lowering your blood sugar that way.
Because these medications use entirely different mechanisms, combining them can be effective for blood sugar control. However, their combined effect means your blood sugar can drop lower than when taking either medication alone.
The Main Concern: Low Blood Sugar (Hypoglycemia)
The primary concern with taking insulin glargine and dapagliflozin together is the increased risk of low blood sugar, or hypoglycemia. When you combine a medication that adds insulin with one that removes glucose through urine, your blood sugar can drop more significantly than expected.
According to the U.S. FDA label for insulin glargine, hypoglycemia is a known risk—especially when insulin is combined with other diabetes medications that lower blood sugar. Watch for these symptoms:
- Shakiness or trembling
- Sweating (especially at night)
- Rapid heartbeat
- Anxiety or nervousness
- Irritability or mood changes
- Difficulty concentrating
- Blurred vision
- Tingling around the mouth
- Severe cases: confusion, loss of consciousness, or seizures
If you experience any of these symptoms, treat low blood sugar immediately with fast-acting carbohydrates like juice, glucose tablets, or honey. Always carry a glucose source with you and inform family members about hypoglycemia symptoms.
Other Important Safety Considerations
Beyond the hypoglycemia risk, there are additional safety points from FDA labeling you should be aware of:
Diabetic Ketoacidosis (DKA)
The U.S. FDA label for dapagliflozin includes a warning about diabetic ketoacidosis (DKA), a serious condition where your blood becomes too acidic. This risk is heightened when SGLT2 inhibitors are combined with insulin. While this complication is rare, you need to recognize warning signs:
- Difficulty breathing
- Nausea or vomiting
- Unusual fatigue
- Abdominal pain
- Fruity-smelling breath
Seek emergency medical attention immediately if you experience these symptoms. This is not something to wait out at home.
Urinary Tract and Genital Infections
FDA drug labeling for dapagliflozin notes an increased risk of urinary tract infections and genital yeast infections because the medication increases glucose in your urine. This environment favors bacterial and fungal growth. While usually not serious, these infections can be uncomfortable and may require antibiotic or antifungal treatment.
Maintain good hygiene practices, stay hydrated, and report any burning during urination or unusual discharge to your doctor.
Kidney Function Monitoring
Both medications can affect kidney function. Your doctor should monitor your kidney function with regular blood tests, especially when you first start this combination or if you have existing kidney concerns. Never skip these appointments—they help catch problems early.
What Your Dosing Might Look Like
Because of the hypoglycemia risk, your doctor may need to adjust your insulin glargine dose downward when adding dapagliflozin. This is completely normal and expected. Your doctor might also recommend more frequent blood sugar monitoring, especially when you first start dapagliflozin or if either dose changes.
Never adjust your insulin dose on your own without speaking to your doctor. Insulin dosing is highly individualized, and what works for someone else may not be right for you.
Managing This Combination Safely
- Monitor blood sugar regularly as directed by your healthcare provider—this might mean checking more often than before
- Keep all appointments with your doctor and lab work scheduled for kidney and metabolic monitoring
- Report side effects immediately, especially signs of low blood sugar, DKA, or infections
- Carry identification stating you have diabetes and use insulin
- Keep glucose source available at all times
- Inform all healthcare providers about both medications, including dentists and emergency responders
- Stay hydrated throughout the day
- Follow dietary recommendations from your diabetes educator or nutritionist
The Bottom Line
Taking insulin glargine and dapagliflozin together is a legitimate treatment approach many people with type 2 diabetes use successfully. According to FDA drug labeling, there's no documented direct drug interaction between these medications—but their combined blood-sugar-lowering effects require vigilance on your part.
Your responsibility is to recognize warning signs, maintain regular medical appointments, check your blood sugar as directed, and communicate openly with your doctor about how you're feeling. This combination can work well for you when managed properly.
Always consult your pharmacist or physician before starting, stopping, or changing any medication. Never use this information as a substitute for professional medical advice. If you're taking multiple medications and want to understand all possible interactions, use checkdruginteractions.com—the most comprehensive drug interaction checker on the internet. Our database contains over 250,000 FDA-labeled drug records, so you can verify interactions with confidence.
Check your full medication list for interactions
The most comprehensive drug interaction checker on the internet — backed by over 250,000 official FDA drug labels and NIH data. No account needed.
Drug interaction data sourced from U.S. FDA drug labeling via openFDA and the U.S. National Library of Medicine (NLM), National Institutes of Health. For informational purposes only. Always consult your pharmacist or physician before making any medication decisions.
Related Posts
Carbamazepine and Phenytoin Interaction: Why Your Seizure Medication Levels May Drop
Learn about the moderate interaction between carbamazepine and phenytoin. FDA data shows phenytoin reduces carbamazepine levels via CYP3A4 induction.
Gabapentin and Pregabalin: Mechanism, Monitoring, and Clinical Considerations for Dual Therapy
Clinical review of gabapentin and pregabalin coadministration. FDA labeling data, pharmacokinetics, monitoring parameters, and dosing considerations.
Liraglutide and Canagliflozin Together: What FDA Data Reveals About This Diabetes Combination
Explore liraglutide and canagliflozin combination therapy with FDA drug labeling data. Safety profile, benefits, and monitoring guidelines.